share_log

Star Equity (NASDAQ:STRRP) Trading 0.6% Higher

Star Equity (NASDAQ:STRRP) Trading 0.6% Higher

Star Equity(納斯達克股票代碼:STRRP)交易價格上漲0.6%
Defense World ·  2023/04/19 14:54

Star Equity Holdings, Inc. (NASDAQ:STRRP – Get Rating) shot up 0.6% on Tuesday . The stock traded as high as $8.48 and last traded at $8.35. 588 shares traded hands during trading, a decline of 71% from the average session volume of 2,011 shares. The stock had previously closed at $8.30.

Star Equity Holdings, Inc.(納斯達克股票代碼:STRRP — 獲取評級)週二上漲了0.6%。該股交易價格高達8.48美元,最後一次交易價格爲8.35美元。交易期間有588股交易,較2,011股的平均交易量下降了71%。該股此前收於8.30美元。

Star Equity Price Performance

明星股票價格表現

The stock has a fifty day simple moving average of $8.43 and a two-hundred day simple moving average of $9.17.

該股的五十天簡單移動平均線爲8.43美元,兩百天簡單移動平均線爲9.17美元。

Get
獲取
Star Equity
明星股權
alerts:
警報:

Star Equity Dividend Announcement

明星股票分紅公告

The business also recently declared a quarterly dividend, which was paid on Friday, March 10th. Stockholders of record on Wednesday, March 1st were issued a $0.25 dividend. The ex-dividend date of this dividend was Tuesday, February 28th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 11.98%.

該公司最近還宣佈了季度股息,該股息已於3月10日星期五支付。3月1日星期三的登記股東獲得了0.25美元的股息。該股息的除息日爲2月28日星期二。這意味着按年計算的股息爲1.00美元,股息收益率爲11.98%。

Insider Buying and Selling

內幕買入和賣出

In related news, major shareholder Jeffrey E. Eberwein bought 84,303 shares of the firm's stock in a transaction that occurred on Friday, February 17th. The shares were acquired at an average cost of $0.97 per share, with a total value of $81,773.91. Following the completion of the transaction, the insider now owns 2,104,592 shares of the company's stock, valued at $2,041,454.24. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In related news, major shareholder Jeffrey E. Eberwein purchased 50,000 shares of the stock in a transaction that occurred on Friday, March 24th. The stock was purchased at an average cost of $0.84 per share, for a total transaction of $42,000.00. Following the acquisition, the insider now owns 2,250,000 shares in the company, valued at $1,890,000. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, major shareholder Jeffrey E. Eberwein acquired 84,303 shares of the stock in a transaction on Friday, February 17th. The stock was purchased at an average cost of $0.97 per share, with a total value of $81,773.91. Following the transaction, the insider now directly owns 2,104,592 shares of the company's stock, valued at $2,041,454.24. The disclosure for this purchase can be found here. Over the last 90 days, insiders have bought 150,417 shares of company stock worth $139,566.

在相關新聞中,主要股東傑弗裏·埃伯溫在2月17日星期五進行的一筆交易中購買了該公司84,303股股票。這些股票的收購平均成本爲每股0.97美元,總價值爲81,773.91美元。交易完成後,該內部人士現在擁有該公司2,104,592股股票,價值2,041,454.24美元。該交易已在向美國證券交易委員會提交的文件中披露,該文件可在以下網址查閱 美國證券交易委員會網站。在相關新聞中,主要股東傑弗裏·埃伯溫在3月24日星期五進行的一筆交易中購買了5萬股股票。購買該股票的平均成本爲每股0.84美元,總交易額爲42,000.00美元。收購後,該內部人士現在擁有該公司225萬股股票,價值189萬美元。該交易是在向美國證券交易委員會提交的文件中披露的,該文件可通過以下方式獲得 這個超鏈接。此外,主要股東傑弗裏·埃伯溫在2月17日星期五的一筆交易中收購了該股84,303股股票。該股票的平均購買成本爲每股0.97美元,總價值爲81,773.91美元。交易完成後,該內部人士現在直接擁有該公司2,104,592股股票,價值2,041,454.24美元。本次收購的披露可以找到 這裏。在過去的90天裏,內部人士購買了150,417股公司股票,價值139,566美元。

Star Equity Company Profile

明星股權公司簡介

(Get Rating)

(獲取評級)

Star Equity Holdings, Inc provides healthcare solutions in the United States and internationally. It operates through four segments: Diagnostic Services, Diagnostic Imaging, Construction, and Investments. It offers imaging services primarily to cardiologists, internal medicine physicians, and family practice doctors; and imaging systems, including nuclear cardiac and general purpose nuclear imaging systems to physician offices and hospitals.

Star Equity Holdings, Inc在美國和國際上提供醫療保健解決方案。它通過四個部門運營:診斷服務、診斷成像、建築和投資。它主要爲心臟病專家、內科醫生和家庭執業醫生提供成像服務;爲醫生辦公室和醫院提供成像系統,包括核心髒和通用核成像系統。

See Also

另請參閱

  • Get a free copy of the StockNews.com research report on Star Equity (STRRP)
  • Gamida Cell Stock Jumps Over 100% on FDA Approval
  • Insiders Buy EasyJet, Regularly And Repeatedly
  • Bank of America Beats Earnings, Renews Investor Upside Potential
  • The Analysts See A Bright Future For Sunrun
  • J.B. Hunt: Economic Contraction And A Buying Opportunity
  • 免費獲取 StockNews.com Star Equity(STRRP)研究報告的副本
  • 經美國食品藥品管理局批准,Gamida Cell的股票上漲了100%以上
  • 內部人士定期反覆收購易捷航空
  • 美國銀行超過收益,重新激發了投資者的上行潛力
  • 分析師認爲Sunrun的前景光明
  • J.B. Hunt:經濟收縮和買入機會

Receive News & Ratings for Star Equity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Star Equity and related companies with MarketBeat.com's FREE daily email newsletter.

接收《星際股票日報》的新聞和評級 -在下面輸入您的電子郵件地址,即可通過Marketbeat.com的免費每日電子郵件時事通訊接收Star Equity及相關公司的最新新聞和分析師評級的簡明每日摘要。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論